Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL

por Sun, Clare, Gaglione, Erika M, Vaughn, Lauren T, Mu, Rui, Underbayev, Chingiz, Chen, Jonathan, Pleyer, Christopher, Wiestner, Adrian
Publicado 2021

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

por Pleyer, Christopher, Ali, Mir A., Cohen, Jeffrey I., Tian, Xin, Soto, Susan, Ahn, Inhye E., Gaglione, Erika M., Nierman, Pia, Marti, Gerald E., Hesdorffer, Charles, Lotter, Jennifer, Superata, Jeanine, Wiestner, Adrian, Sun, Clare
Publicado 2021

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

por Cyr, Matthew G, Mhibik, Maissa, Qi, Junpeng, Peng, Haiyong, Chang, Jing, Gaglione, Erika M, Eik, David, Herrick, John, Venables, Thomas, Novick, Scott J, Courouble, Valentine V, Griffin, Patrick R, Wiestner, Adrian, Rader, Christoph
Publicado 2022

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

por Mhibik, Maissa, Gaglione, Erika M., Eik, David, Herrick, John, Le, Janet, Ahn, Inhye E., Chiu, Christopher, Wielgos-Bonvallet, Monica, Hiemstra, Ida H., Breij, Esther C. W., Chen, Jenny, Reilly, Edward B., Epling-Burnette, Pearlie K., Szafer-Glusman, Edith, Sun, Clare, Wiestner, Adrian
Publicado 2023